USPTO serial 79399254
2BIND
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 11, 2025
- Examiner
- HUDSON, TAMARA BREE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with 2BIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Regensburg, DE
Regensburg, DE
Regensburg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological agents, compounds, preparations, reagents and substances for scientific, research, laboratory, industrial and commercial purposes ‘other than for medical and veterinary purposes; chemical, biochemical and biological preparations for use in biophysical and biotechnological process for scientific, research, laboratory, industrial and commercial purposes; diagnostic reagents, buffers, buffer solutions, buffer-screening stock solutions, bioliquids, ligands, HIV-immunogens, antibodies, in particular therapeutic antibodies, monoclonal antibodies, antibody reagents, proteins, aptamers, antigens, biochemicals for in vitro and in vivo applications for scientific, research, laboratory, industrial and commercial purposes, all the aforesaid except for medical and veterinary purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical, biochemical and biological agents, compounds, preparations, reagents and substances for the development, manufacture and research in the fields of biology, biotechnology, biochemistry, chemistry, pharmacy and cosmetics‘ other than for medical and veterinary purposes; chemical, biochemical and biological agents, compounds, preparations, reagents and substances for scientific and medical research and for scientific research and development in the field of medicine; chemical, biochemical and biological preparations for the research and development of biophysical and biotechnological products; chemical, biochemical and biological agents, compounds, preparations, reagents and substances for the manufacture of medicine and pharmaceutical preparations; chemical, biochemical and biological preparations for the manufacture of biophysical and biotechnological products; chemicals and chemical agents, compounds, preparations, reagents and substances for laboratory analysis, in particular bacterial preparations and bacteriological preparations, except for medical and veterinary purposes | ACTIVE | — |
| 042 | Scientific research services, namely, conducting of biophysical interactions analyses for determining binding parameters of molecular interactions; scientific laboratory services, namely, plasmid cloning, protein expression in e.coli, protein purification and fluorescent protein marking; science and technology research services; research and development services in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry and cosmetology; medical and pharmaceutical research and development; scientific, technological and industrial analysis and research in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry, agrochemistry and cosmetology; scientific laboratory services; research laboratory services; analytical laboratory services; laboratory testing services for scientific research; scientific research in the nature of conducting of scientific experiments and tests; consultancy in the field of scientific, industrial and technological research and development; providing of information relating to industrial and scientific analysis, research and development in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry, agrochemistry and cosmetology; providing of information relating to technological research and development in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry, agrochemistry and cosmetology; industrial development services in the fields of engineering, biophysics, bioinformatics, pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry, agrochemistry and cosmetology; conducting scientific studies for others in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry, agrochemistry and cosmetology; development of industrial processes for others; development of new products for others; development of new technology for others; development and testing of chemical, biochemical and biological manufacturing processes; research and development in the nature of developing testing methods and research and development services for developing methods of testing; development of machining techniques; research and development relating to medicines, pharmaceuticals, medical goods, diagnostics, diagnostic and analysis goods, food, cosmetics, cleaning preparations and disinfectants; research and development services and industrial, scientific and technological laboratory services relating to protein and RNA-based medicine development, antibody development, protein analysis, aptamer development and the determination of molecular interactions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 29, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 11, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 25, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 11, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 29, 2025 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Sep 29, 2025 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 25, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2025 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Aug 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 28, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 28, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2025 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 11, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 11, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2024 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |